Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells
- 1 October 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 56 (8) , 1029-1034
- https://doi.org/10.1016/s0006-2952(98)00149-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Novobiocin modulates colchicine sensitivity in parental and multidrug-resistant B16 melanoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Diazepam binding inhibitor (DBI): A peptide with multiple biological actionsLife Sciences, 1991
- Stimulation of cell growth and DNA synthesis by peripheral benzodiazepineCancer Letters, 1990
- Antiproliferative Action of Benzodiazepines in Cultured Brain Cells Is Not Mediated Through the Peripheral‐Type Benzodiazepine AcceptorJournal of Neurochemistry, 1989
- Superinduction of c- fos by Nerve Growth Factor in the Presence of Peripherally Active BenzodiazepinesScience, 1985
- Benzodiazepines that bind at peripheral sites inhibit cell proliferation.Proceedings of the National Academy of Sciences, 1984
- Characterization of a peripheral-type benzodiazepine binding site on human circulating lymphocytesEuropean Journal of Pharmacology, 1983
- A Detergent‐trypsin method for the preparation of nuclei for flow cytometric DNA analysisCytometry, 1983
- Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells.Proceedings of the National Academy of Sciences, 1981
- Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cellsNature, 1980